| Wada Optometry, Inc. | |
|
936 S Brookhurst St, Anaheim, CA 92804-4305 | |
| (714) 533-2525 | |
| (714) 242-9564 |
| Full Name | Wada Optometry, Inc. |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 936 S Brookhurst St, Anaheim, California |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184744641 | NPI | - | NPPES |
| SD010097 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 10097T (California) | Primary |
| Provider Name | Garrett S Wada |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1033172903 PECOS PAC ID: 6608763040 Enrollment ID: I20040301001307 |
News Archive
Scientists have discovered the reason why patients who show brain markers for Alzheimer's never develop the condition.
In the EVICURES project a design model for future intensive and intermediate care facilities was developed at Seinäjoki Central Hospital. The results of research conducted by VTT Technical Research Centre of Finland Ltd on evidence-based design (EBD) and user-orientation were applied to the design work.
The billions of microorganisms living within the human digestive tract appear to play a significant role in health and disease, notably metabolic syndrome, autoimmune disorders and diabetes - but how these organisms do so is not well understood.
Physical therapist-directed exercise counseling combined with fitness center-based exercise training can improve muscular strength and exercise capacity in people with type 2 diabetes, with outcomes similar to those of supervised exercise, according to a randomized clinical trial published in the September issue of Physical Therapy, the scientific journal of the American Physical Therapy Association (APTA).
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.
› Verified 4 days ago
| Provider Name | Jimmy Minh Quang |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1932655164 PECOS PAC ID: 7810278488 Enrollment ID: I20161220001522 |
News Archive
Scientists have discovered the reason why patients who show brain markers for Alzheimer's never develop the condition.
In the EVICURES project a design model for future intensive and intermediate care facilities was developed at Seinäjoki Central Hospital. The results of research conducted by VTT Technical Research Centre of Finland Ltd on evidence-based design (EBD) and user-orientation were applied to the design work.
The billions of microorganisms living within the human digestive tract appear to play a significant role in health and disease, notably metabolic syndrome, autoimmune disorders and diabetes - but how these organisms do so is not well understood.
Physical therapist-directed exercise counseling combined with fitness center-based exercise training can improve muscular strength and exercise capacity in people with type 2 diabetes, with outcomes similar to those of supervised exercise, according to a randomized clinical trial published in the September issue of Physical Therapy, the scientific journal of the American Physical Therapy Association (APTA).
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wada Optometry, Inc. 936 S Brookhurst St, Anaheim, CA 92804-4305 Ph: (714) 533-2525 | Wada Optometry, Inc. 936 S Brookhurst St, Anaheim, CA 92804-4305 Ph: (714) 533-2525 |
News Archive
Scientists have discovered the reason why patients who show brain markers for Alzheimer's never develop the condition.
In the EVICURES project a design model for future intensive and intermediate care facilities was developed at Seinäjoki Central Hospital. The results of research conducted by VTT Technical Research Centre of Finland Ltd on evidence-based design (EBD) and user-orientation were applied to the design work.
The billions of microorganisms living within the human digestive tract appear to play a significant role in health and disease, notably metabolic syndrome, autoimmune disorders and diabetes - but how these organisms do so is not well understood.
Physical therapist-directed exercise counseling combined with fitness center-based exercise training can improve muscular strength and exercise capacity in people with type 2 diabetes, with outcomes similar to those of supervised exercise, according to a randomized clinical trial published in the September issue of Physical Therapy, the scientific journal of the American Physical Therapy Association (APTA).
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.
› Verified 4 days ago
Tina Do Optometry, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 440 N Euclid St, Anaheim, CA 92801 Phone: 714-956-2785 | |
Dr. Derek Kwon Optometry, Inc Optometrist Medicare: Medicare Enrolled Practice Location: 731 N Euclid St, Anaheim, CA 92801 Phone: 714-533-8240 | |
Krupa J Patel, OD Optometrist Medicare: Medicare Enrolled Practice Location: 5460 E La Palma Ave, Anaheim, CA 92807 Phone: 714-463-7569 | |
Dr. Garrett Scott Wada, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 936 S Brookhurst St, Anaheim, CA 92804 Phone: 714-533-2525 Fax: 714-242-9564 | |
Ely R Almaleh, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Steven Hoffman, Optometrist Medicare: Medicare Enrolled Practice Location: 5460 E La Palma Ave, Anaheim, CA 92807 Phone: 714-463-7500 Fax: 714-992-7850 | |
Ms. Teresa Xuan Do, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 500 S Euclid St Ste D, Anaheim, CA 92802 Phone: 714-635-1100 Fax: 714-635-1155 |